10 assets in Desmoplastic Small Round Cell Tumor

Therapeutic assets addressing Desmoplastic Small Round Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Desmoplastic Small Round Cell Tumor	St. Jude Children's Research Hospital	P2	B (60)
Fludarabine Desmoplastic Small Round Cell Tumor	St. Jude Children's Research Hospital	P2	B (59)
Omburtamab Desmoplastic Small Round Cell Tumor	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Zoledronate Desmoplastic Small Round Cell Tumor	University of Florida	P1/2	CCC (48)
b7-h3 car t cells Desmoplastic Small Round Cell Tumor	St. Jude Children's Research Hospital	P1	CC (43)
Mesna Desmoplastic Small Round Cell Tumor	St. Jude Children's Research Hospital	P1	CC (43)
Pembrolizumab Desmoplastic Small Round Cell Tumor	Seattle Children's Hospital	P1	CC (43)
Second Generation 4-1Bbζ B7H3-Egfrt-Dhfr Desmoplastic Small Round Cell Tumor	Seattle Children's Hospital	P1	CC (43)
Second Generation 4-1Bbζ Egfr806-Egfrt Desmoplastic Small Round Cell Tumor	Seattle Children's Hospital	P1	CC (43)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg Desmoplastic Small Round Cell Tumor	Seattle Children's Hospital	P1	CC (43)